<qa>  What is the STUDY TO ASSESS?A STUDY TO ASSESS THE EFFICACY AND SAFETY OF FARLETUZUMAB MORAB 003 IN COMBINATION WITH CARBOPLATIN PLUS PACLITAXEL OR CARBOPLATIN PLUS PEGYLATED LIPOSOMAL DOXORUBICIN PLD IN SUBJECTS WITH LOW CA125 PLATINUM-SENSITIVE OVARIAN CANCER: 